A 38-year-old woman with newly diagnosed Hashimoto's thyroiditis (TSH 12.3 mIU/L, free T4 0.6 ng/dL) is started on thyroid replacement. She reports taking metformin, omeprazole, and a calcium supplement. After 6 weeks on levothyroxine 50 mcg daily, her TSH remains elevated at 9.8 mIU/L. Which single intervention is most likely to improve her response?

Explanation

## Optimizing Levothyroxine Absorption in Hypothyroidism **Key Point:** Drug and nutrient interactions significantly impair levothyroxine absorption; timing separation is the first intervention before dose escalation. ### Mechanism of Malabsorption Levothyroxine is absorbed in the small intestine via specific transporters. Several agents chelate or interfere with absorption: | Agent | Mechanism | Recommended Separation | | --- | --- | --- | | **Calcium supplements** | Forms insoluble complexes with levothyroxine | ≥4 hours | | **Iron supplements** | Chelates levothyroxine | ≥4 hours | | **Proton pump inhibitors (omeprazole)** | Reduces gastric acid → impairs dissolution and absorption | ≥4 hours | | **H₂ blockers** | Reduces gastric acid | ≥2 hours | | **Antacids** | Chelates levothyroxine | ≥4 hours | | **Sucralfate** | Binds levothyroxine | ≥4 hours | **High-Yield:** The patient in this case is taking **both omeprazole and calcium**, creating a double absorption barrier. This is a classic NEET PG trap. ### Clinical Approach 1. **Assess adherence and absorption first** — before increasing dose. 2. **Separate medications**: Take levothyroxine on an empty stomach, 30–60 minutes before breakfast. Take calcium and omeprazole at least 4 hours later (e.g., with lunch or dinner). 3. **Recheck TSH in 6–8 weeks** — if absorption is restored, TSH should normalize without dose increase. 4. **Only escalate dose** if absorption is optimized and TSH remains high. **Clinical Pearl:** Patients often report "levothyroxine doesn't work" when the real issue is drug interaction. A careful medication history and timing adjustment can resolve apparent "treatment resistance." ### Why Not the Other Options? **Liothyronine (Option B):** Switching to T3 is inappropriate here because the problem is absorption, not the drug itself. Liothyronine has a shorter half-life and would require multiple daily doses, worsening compliance. It is not first-line for chronic replacement. **Selenium (Option D):** While selenium is a cofactor for glutathione peroxidase (which protects thyroid tissue in autoimmune thyroiditis), supplementation is not standard practice and does not improve levothyroxine absorption or TSH control in routine hypothyroidism. **Dose increase (Option A):** Increasing to 75 mcg without addressing the absorption barrier will not improve TSH; it may even worsen symptoms if the patient is already absorbing some drug.